Search Results

Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors

Authors: Keller, Guillermo A.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 73-78(6)

Publisher: Bentham Science Publishers

Safety of dermal Diphoterine^® application: An active decontamination solution for chemical splash injuries

Authors: Hall, Alan H.; Cavallini, Maurizio; Mathieu, Laurence; Maibach, Howard I.

Source: Cutaneous and Ocular Toxicology (formerly Journal of Toxicology - Cutaneous and, Volume 28, Number 4, December 2009 , pp. 149-156(8)

Publisher: Informa Healthcare

Transdermal contraceptive patches: current status and future potential

Authors: Milanes-Skopp, Rose; Nelson, Anita L

Source: Expert Review of Clinical Pharmacology, Volume 2, Number 6, November 2009 , pp. 601-607(7)

Publisher: Expert Reviews

Prevnar batch suspended after three infant deaths

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 2-2(1)

Publisher: Adis International

Benefit-Risk Assessment of Leflunomide: An Appraisal of Leflunomide in Rheumatoid Arthritis 10 Years After Licensing

Authors: Alcorn, Nicola; Saunders, Sarah; Madhok, Rajan

Source: Drug Safety, Volume 32, Number 12, 1 December 2009 , pp. 1123-1134(12)

Publisher: Adis International

Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination

Authors: Cady, Roger K.; Banks, James; Jones, Beverly A.; Campbell, John

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2711-2721(11)

Publisher: Informa Healthcare

Natalizumab doing well outside phase III trials

Source: Reactions, Volume 1, Number 1275, 2009-10-24 , pp. 5-5(1)

Publisher: Adis International

Newer Biological Agents in the Treatment of Rheumatoid Arthritis: Do the Benefits Outweigh the Risks?

Author: Nurmohamed, Michael T.

Source: Drugs, Volume 69, Number 15, 22 October 2009 , pp. 2035-2043(9)

Publisher: Adis International

Industry improves on-time performance of PMS studies

Source: Reactions, Volume 1, Number 1269, 2009-09-12 , pp. 2-2(1)

Publisher: Adis International

Tradition rules in signal detection?

Source: Reactions, Volume 1, Number 1263, 2009-08-01 , pp. 1-1(1)

Publisher: Adis International

Safety and tolerability of ribosome-component immune modulator in adults and children

Authors: Olivieri, Dario; Fiocchi, Alessandro; Pregliasco, Fabrizio; Veehof, Suzanne; Cantoni, Vittorio

Source: Allergy and Asthma Proceedings, Volume 30, Supplement 1, July/August 2009 , pp. S33-S36(1)

Publisher: OceanSide Publications, Inc

Ezetimibe/HMG-CoA reductase inhibitors: Amyotrophic lateral sclerosis-like conditions: 10 case reports

Source: Reactions, Volume 1, Number 1264, 2009-08-08 , pp. 17-18(2)

Publisher: Adis International

Overview of Seizure-Inducing Potential of Doripenem

Authors: Zhanel, George G.; Ketter, Nzeera; Rubinstein, Ethan; Friedland, Ian; Redman, Rebecca

Source: Drug Safety, Volume 32, Number 9, 1 September 2009 , pp. 709-716(8)

Publisher: Adis International

Comparative Tolerability of Newer Agents for Insomnia

Author: Zammit, Gary

Source: Drug Safety, Volume 32, Number 9, 1 September 2009 , pp. 735-748(14)

Publisher: Adis International

Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999-2002

Authors: Bottone, Frank G.; Barry, William T.

Source: Current Medical Research and Opinion, Volume 25, Number 6, June 2009 , pp. 1535-1550(16)

Publisher: Informa Healthcare

Levofloxacin 0.5% Ophthalmic Solution: A Review of its Use in the Treatment of External Ocular Infections and in Intraocular Surgery

Author: Keating, Gillian M.

Source: Drugs, Volume 69, Number 9, 18 June 2009 , pp. 1267-1286(20)

Publisher: Adis International

Injection-site reactions were the most common adverse event (AE) observed during a Japanese postmarketing surveillance study of etanercept

Source: Reactions, Volume 1, Number 1258, 2009-06-27 , pp. 3-3(1)

Publisher: Adis International

Memantine in Moderately-Severe-to-Severe Alzheimer's Disease: A Postmarketing Surveillance Study

Authors: Clerici, Francesca; Vanacore, Nicola; Elia, Antonietta; Spila-Alegiani, Stefania; Pomati, Simone; >Roberto Da Cas,; Raschetti, Roberto; Mariani, Claudio

Source: Drugs & Aging, Volume 26, Number 4, 28 May 2009 , pp. 321-332(12)

Publisher: Adis International

Review of 8 years of experience with Infanrix hexa™ (DTPa-HBV-IPV/Hib hexavalent vaccine)

Authors: Zepp, Fred; Schmitt, Heinz-Josef; Cleerbout, Jan; Verstraeten, Thomas; Schuerman, Lode; Jacquet, Jeanne-Marie

Source: Expert Review of Vaccines, Volume 8, Number 6, June 2009 , pp. 663-678(16)

Publisher: Expert Reviews

Toenail Onychomycosis in Diabetic Patients: Issues and Management

Authors: Mayser, Peter; Freund, Viviane; Budihardja, Debby

Source: American Journal of Clinical Dermatology, Volume 10, Number 4, 3 June 2009 , pp. 211-220(10)

Publisher: Adis International